The poor relations
Article Abstract:
The interests of private investors sometimes appear to be ignored when changes occur on the United Kingdom stock market. Nominee accounts have been promoted as the result of a new electronic stock settlement system called Crest and stockholders lose some benefits of direct ownership of stocks if they use nominee accounts. Private investors do not have to be included in Stock Exchange flotations. They may also suffer handicaps with the new trading structure to be implemented from Oct 1997 which excludes deals of under 4,000 pounds sterling.
Publication Name: Investors Chronicle
Subject: Business
ISSN: 0261-3115
Year: 1997
User Contributions:
Comment about this article or add new information about this topic:
EASI does it
Article Abstract:
EASDAQ was set up by European securities dealers, investment bankers and venture capitalists with the goal of floating fast growing and innovative European firms on a wide market. The focus was on telecoms, engineering, biotechnology and other high-growth areas. A pan-European dealing system has developed which takes NASDAQ as its model. There are 69 members such as stockbrokers and banks, and 37 listings. EASDAQ aims to increase numbers of both listings and members.
Publication Name: Investors Chronicle
Subject: Business
ISSN: 0261-3115
Year: 1998
User Contributions:
Comment about this article or add new information about this topic:
Quiet time for new market romantics
Article Abstract:
Germany Neuer Markt stock exchange is working to repair the damage done to its reputation by several scandals and claims of weak regulations. Despite problems, Neuer Markt is still the most liquid of the European new markets.
Publication Name: Investors Chronicle
Subject: Business
ISSN: 0261-3115
Year: 2001
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: The million dollar questions. Goal for Gaelco. A bridge too far?
- Abstracts: Gordon Productions. CMG Productions
- Abstracts: Truth or dare. Why model? Taking a Second Look at Customers
- Abstracts: Hard cash for hard times. I see cash in your future. Got cash? Who doesn't?
- Abstracts: Hemispherx BioPharma (HEB). DrugAbuse Sciences, Inc. AtheroGenics, Inc. (AGIX)